The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

USANA Health Sciences Inc

NYSE: USNA
Last

(U.S.) $119.54

Today's change-5.33 -4.27%
Updated February 9 4:02 PM EST. Delayed by at least 15 minutes.
 

USANA Health Sciences Inc

NYSE: USNA
Last

(U.S.) $119.54

Today's change-5.33 -4.27%
Updated February 9 4:02 PM EST. Delayed by at least 15 minutes.

Sharp drop following new 20-day high

USANA Health Sciences Inc closed sharply lower Tuesday, dropping (U.S.)$5.33 or 4.27% to (U.S.)$119.54 after setting a new 20-day high. Over the last five days, shares have lost 1.08% and are down 6.43% for the last year to date. This security has outperformed the S&P 500 by 22.10% during the last year.

Key company metrics

  • Open(U.S.) $136.32
  • Previous close(U.S.) $124.87
  • High(U.S.) $136.32
  • Low(U.S.) $118.87
  • Bid / Ask(U.S.) $107.50 / (U.S.) $109.00
  • YTD % change-6.43%
  • Volume226,653
  • Average volume (10-day)146,034
  • Average volume (1-month)138,338
  • Average volume (3-month)134,491
  • 52-week range(U.S.) $96.04 to (U.S.) $176.88
  • Beta1.22
  • Trailing P/E17.07×
  • P/E 1 year forward17.01×
  • Forward PEG1.70×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $7.00
Updated February 9 4:02 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+10.07%

Based on its net profit margin of 10.07%, USANA Health Sciences Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX2.02%Sector:Non-Cyclical Consumer Goods & ServicesIndustry:Personal Products
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2015Q2/2015Q1/2015Q4/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedOct 03, 201510/03/2015Jul 04, 201507/04/2015Apr 04, 201504/04/2015Jan 03, 201501/03/2015
Revenue233233219228
Total other revenue--------
Total revenue233233219228
Gross profit192193181190
Total cost of revenue41403838
Total operating expense195194190195
Selling / general / administrative154154151158
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income38393033
Interest income (expense), net non-operating0000
Gain (loss) on sale of assets--------
Other--------
Income before tax38393032
Income after tax26252021
Income tax, total13131011
Net income26252021
Total adjustments to net income--------
Net income before extra. items26252021
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items26252021
Inc. avail. to common incl. extra. items26252021
Diluted net income26252021
Dilution adjustment--0----
Diluted weighted average shares13131313
Diluted EPS excluding extraordinary itemsvalue per share1.921.921.501.66
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share1.921.921.501.66